viability human htb140 melanoma cells exposed fotemustine fm dacarbazine dtic proton irradiation studied effects NUMBER NUMBER microm drugs assessed incubation NUMBER NUMBER NUMBER NUMBER NUMBER h irradiations performed NUMBER mev therapeutic protons delivering cell monolayer single doses NUMBER NUMBER NUMBER NUMBER NUMBER gy viability evaluated NUMBER days irradiation inactivation level estimated using microtetrasolium mtt sulforhodamine b srb assays combined effects drug protons carried using drug concentrations proton doses applied used therapy NUMBER NUMBER gy increase drug concentration irradiation dose level cell inactivation reached approximately NUMBER NUMBER h drug treatment NUMBER days irradiation NUMBER gy considering rate drug concentrations used level doses applied appears htb140 cells resistant proton irradiation alkylating agents tested combined treatment fm dtic protons did significant changes cell viability compared effects single agents time point measuring cumulative effects drug irradiation NUMBER h post irradiation obtained level viability attributed primarily effects drugs